Sanegene Bio: Funding, Investors & Team (Sep 2026)
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs. Its RNAi portfolio covers a broad range of therapeutic areas including cardiovascular and metabolic diseases, immunology-related diseases, and nervous system diseases
Sanegene Bio has raised $110M across 1 funding round on record, the most recent a Series B of $110M announced in Dec 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Sanegene Bio Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Sanegene Bio Funding Rounds
Sanegene Bio Founders and Leadership Team
Contact details for the Sanegene Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Sanegene Bio Funding Compared to Other Biotechnology Startups
Sanegene Bio's latest round of $110M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sanegene Bio in Biotechnology and Woburn
Companies Similar to Sanegene Bio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Sanegene Bio Funding FAQs
What does Sanegene Bio do?
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs. Its RNAi portfolio covers a broad range of therapeutic areas including cardiovascular and metabolic diseases, immunology-related diseases, and nervous system diseases
How much funding has Sanegene Bio raised?
Sanegene Bio has raised $110M across 1 round on record. The most recent is a Series B of $110M announced in Dec 2025.
When did Sanegene Bio last raise funding?
Sanegene Bio's most recent funding round on record is a Series B of $110M, announced in Dec 2025.
Who founded Sanegene Bio?
FundedIQ lists Weimin Wang (Founder) at Sanegene Bio.
Where is Sanegene Bio headquartered?
Sanegene Bio is based in Woburn, Massachusetts, United States.
How many employees does Sanegene Bio have?
Sanegene Bio is in the 51-100 employee band.
How does Sanegene Bio's funding compare to other Biotechnology startups?
Sanegene Bio's latest round of $110M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Sanegene Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sanegene Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.